Predicting cetuximab accumulation in KRAS wild‐type and KRAS mutant colorectal cancer using (64)Cu‐labeled cetuximab positron emission tomography

Overexpression of epidermal growth factor receptor (EGFR) is common in colorectal cancer. However, cetuximab as an EGFR‐targeting drug is useful only for a subset of patients and currently no single predictor other than V‐Ki‐ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status has...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Sci
Main Authors: Achmad, Arifudin, Hanaoka, Hirofumi, Yoshioka, Hiroki, Yamamoto, Shinji, Tominaga, Hideyuki, Araki, Takuya, Ohshima, Yasuhiro, Oriuchi, Noboru, Endo, Keigo
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Publishing Ltd 2012
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7713619/
https://ncbi.nlm.nih.gov/pubmed/22126621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2011.02166.x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker